DKK3 Identified as Key Mediator of Long-Term Radiotherapy Skin Damage

Radiotherapy, a primary cancer treatment, often causes long-term side effects such as skin damage, chronic inflammations, and fibroses. Current treatments for such damage are primarily symptomatic, addressing the symptoms rather than the underlying cause.

A significant breakthrough has been made by a research team, including LMU immunologist Professor Peter Nelson, Roger Sandhoff, and Peter E. Huber from the German Cancer Research Center (DKFZ). They have identified Dickkopf 3 (DKK3) as a primary cause of the long-term skin damage observed following radiotherapy.

DKK3 has been identified as a primary cause of long-term skin damage following radiotherapy.

Key Research Findings

The research revealed that DKK3 becomes activated in specific skin cells responsible for renewal after radiotherapy exposure.

This activation subsequently triggers a cascading chain reaction that promotes inflammation and the formation of scar-like tissue, ultimately leading to chronic skin damage.

These pivotal findings were consistently supported by comprehensive research conducted on mouse models, as well as human cells and tissue samples.

LMU students Li Li and Khuram Shehzad were instrumental in contributing to the identification of DKK3 as this critical molecular mediator.

Broader Implications

Beyond skin damage, similar processes involving DKK3 activation were also observed in kidney tissue. This suggests that DKK3 represents a fundamental mechanism contributing to fibrosis across various tissues and organs.

Therapeutic Potential

The researchers highlight that DKK3 stands out as a potential new target for therapeutic intervention. Developing drugs that specifically inhibit DKK3 could offer a novel strategy to prevent or significantly reduce the long-term skin damage experienced by cancer patients after radiotherapy, thereby improving their quality of life.

Investigations are currently underway to determine whether this innovative approach could also be effective in preventing scar formation in other vital organs.